The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for membership on ACET. The ACET consists of 10 experts in
fields associated with public Health, epidemiology, immunology,
infectious diseases, pulmonary disease, pediatrics, tuberculosis,
microbiology, or preventive health care delivery, who are selected by
the Secretary of the United State Department of Health and Human
Services (HHS). ACET provides advice and recommendations to the
Secretary, HHS; the Assistant Secretary of Health; and the Director,
CDC, regarding program policies, strategies, objectives, and
priorities; address the development and application of new
technologies; provide guidance and review on CDC's Tuberculosis
prevention research portfolio and program priorities; and review the
extent to which progress has been made toward eliminating tuberculosis.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
committee's objectives. Nominees will be selected based on expertise in
the field of epidemiology, immunology, infectious diseases, pulmonary
disease, pediatrics, tuberculosis, microbiology, preventive health care
delivery, and experts in public health. Federal employees will not be
considered for membership. Members may be invited to serve for four-
The next cycle of selection of candidates will begin in the Fall of
2016 for selection of potential nominees to replace members whose terms
will end on June 30, 2018. Selection of members is based on candidates'
The U. S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees, requiring the filing of
financial disclosure reports at the beginning and annually during their
terms. CDC reviews potential candidates for ACET membership each year,
and provides a slate of nominees for consideration to the Secretary of
HHS for final selection. HHS notifies selected candidates of their
appointment near the start of the term in July 1, 2018, or as soon as
the HHS selection process is completed. Note that the need for
different expertise varies from year to year and a candidate who is not
selected in one year may be reconsidered in a subsequent year.
Candidates should submit the following items. The deadline for
receipt of materials for the 2017 term is October 31, 2016:
Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
The deadline for receipts of all application materials for
consideration for term beginning July 1, 2018 is due October 31, 2016
electronically or in writing, and must be postmarked by October 31,
Regular, Express or Overnight Mail to: Margie Scott-Cseh, Committee
Management Specialist, NCHHSTP, CDC, 1600 Clifton Road NE., Mailstop:
E07, Atlanta, GA 30329
Electronic submissions may be sent to: email@example.com.
Telephone and facsimile submissions cannot be accepted. Nominations
may be submitted by the candidate or by the person/organization
recommending the candidate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the CDC and the Agency for Toxic Substances and Disease